Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.

For many people with HIV, finding the right doctor is the most important decision they'll make.

Pharmaceutical companies have invested hundreds of millions of dollars in new HIV/AIDS treatments not out of altruism but because they can make up those research costs in sales.

Evan Wolfson is a dear friend of mine. Almost more than any other, Evan is responsible for bringing the issue of marriage equality to the forefront of our struggle for civil rights. He is a courageous pioneer who has been relentless in this battle for marriage equality.

Those of us who lived through the worst of the HIV/AIDS epidemic from the early 1980s through the mid-1990s have a very special spot in our heart for home-based health care.

Treating HIV/AIDS is a lifelong commitment that demands strict adherence to drug protocols, consistent care, and a trusting relationship with health care providers.

Every spring, this country will be reminded of the Lady from Texas. As trees bloom and flowers carpet our nation's capital, Lady Bird Johnson will be remembered. Only Lady Bird Johnson could, with her vision of a beautiful America, lay claim to spring as her memorial.